Somatic mutations in tet methylcytosine dioxygenase 2 (TET2), which encodes an epigenetic modifier enzyme, drive the development of haematopoietic malignancies [1][2] [3] [4] [5] [6] [7] . In both humans and mice, TET2 deficiency leads to increased self-renewal of haematopoietic stem cells with a net developmental bias towards the myeloid lineage TET2 deficiency leads to severe myeloproliferation, extramedullary haematopoiesis and splenomegaly that mimic pre-leukaemic myeloproliferative disorders (henceforth referred to as PMP) 2, [7] [8] [9] . PMP is thought to set the stage for the development of overt leukaemia after the occurrence of additional cooperative oncogenic mutations 10, 11 . To better understand the pathogenesis of PMP, we set out to determine the mechanisms that underlie variations in PMP penetrance, which are observed in around 50-75% of aged Tet2 −/− mice that are over 20 weeks old 8,9 (Extended Data Fig. 1a) . We first developed a peripheral-blood biomarker that could serve as a robust predictor of disease. We found that the frequency of CD11b + Gr1 + myeloid cells in the peripheral blood positively correlates with myeloid proliferations 12 (as defined by the expansion of myeloid cells in the spleen and peripheral blood) and splenic extramedullary haematopoiesis markers 8, 9, 13, 14 (an increase of lineage − Sca1 + c-Kit + (LSK) cells and splenomegaly) (Extended Data Fig. 1b-e) . Confirming the prognostic robustness of this newly defined peripheral-blood biomarker of PMP, Tet2 −/− mice that were over 20 weeks old and had >16% of CD11b
, suggesting that extrinsic non-cell-autonomous factors are required for disease onset. Here we show that bacterial translocation and increased interleukin-6 production, resulting from dysfunction of the small-intestinal barrier, are critical for the development of PMP in mice that lack Tet2 expression in haematopoietic cells. Furthermore, in symptom-free Tet2 −/− mice, PMP can be induced by disrupting intestinal barrier integrity, or in response to systemic bacterial stimuli such as the toll-like receptor 2 agonist. PMP was reversed by antibiotic treatment and failed to develop in germ-free Tet2 −/− mice, which illustrates the importance of microbial signals in the development of this condition. Our findings demonstrate the requirement for microbial-dependent inflammation in the development of PMP and provide a mechanistic basis for the variation in PMP penetrance observed in Tet2 −/− mice. This study will prompt new lines of investigation that may profoundly affect the prevention and management of haematopoietic malignancies.
TET2 deficiency leads to severe myeloproliferation, extramedullary haematopoiesis and splenomegaly that mimic pre-leukaemic myeloproliferative disorders (henceforth referred to as PMP) 2, [7] [8] [9] . PMP is thought to set the stage for the development of overt leukaemia after the occurrence of additional cooperative oncogenic mutations 10, 11 . To better understand the pathogenesis of PMP, we set out to determine the mechanisms that underlie variations in PMP penetrance, which are observed in around 50-75% of aged Tet2 −/− mice that are over 20 weeks old 8, 9 (Extended Data Fig. 1a ). We first developed a peripheral-blood biomarker that could serve as a robust predictor of disease. We found that the frequency of CD11b + Gr1 + myeloid cells in the peripheral blood positively correlates with myeloid proliferations 12 (as defined by the expansion of myeloid cells in the spleen and peripheral blood) and splenic extramedullary haematopoiesis markers 8, 9, 13, 14 (an increase of lineage − Sca1 + c-Kit + (LSK) cells and splenomegaly) (Extended Data Fig. 1b-e) . Confirming the prognostic robustness of this newly defined peripheral-blood biomarker of PMP, Tet2 −/− mice that were over 20 weeks old and had >16% of CD11b
+

Gr1
+ myeloid cells in their peripheral blood displayed a PMP phenotype (Extended Data Fig. 1f-h ) as +/+ and Tet2 −/− mice, respectively) and spleen (right; n = 4, 11 and 19 for germ-free wild-type, Tet2 +/+ and Tet2 −/− mice, respectively). Germ-free wild-type mice served as negative control. Centre at median, two-tailed Mann-Whitney U-test. Bacterial 16S rRNA gene qPCRs from about 30 mg MLN and about 30 mg spleen were normalized to the host murine Ifnb1 gene. c, Correlation between 16S gene copies in the peripheral blood and numbers (left) or frequency (right) of peripheral-blood CD11b + Gr1 + myeloid cells (n = 40 mice). Pearson correlation test. d, Representative image of aerobic and anaerobic cultures. e, f, Quantification of bacteria colony-forming units (CFUs) of MLN and spleen suspensions grown under anaerobic (e) or aerobic (f) conditions. In b, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Data are representative of at least three independent experiments.
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−/− mice with ≤16% peripheral-blood CD11b
+
Gr1
+ cells (defined as 'symptom free'), or littermate controls. We next determined whether differences in PMP penetrance in Tet2 −/− mice (Extended Data Fig. 1a -h) could be linked to a change in the haematopoietic stem cell (HSC) self-renewing potential in vitro 8, 9 . Irrespective of health status, bone marrow and splenic haematopoietic progenitors from symptom-free Tet2 −/− mice and Tet2 −/− mice with PMP displayed similar re-plating efficiencies, which were superior to those of littermate controls ( Fig. 1a and Extended Data Fig. 1i ). This suggests that extrinsic non-cell-autonomous factors are required for the development of PMP in Tet2 −/− mice. This finding, together with previous studies that report that the systemic dissemination of bacteria induces extramedullary haematopoiesis and emergency myelopoiesis 15 , prompted us to investigate whether bacterial triggers could drive myeloproliferation in the absence of Tet2. Quantification of the bacterial 16S rRNA gene revealed the presence of 16S gene copies in the peripheral blood, the mesenteric lymph nodes (MLNs), and the spleen of Tet2 −/− mice (Fig. 1b) that correlated with myelocytosis ( Fig. 1c and Extended Data Fig. 1j, k) . Furthermore, cultivation of MLN and spleen suspensions under aerobic and anaerobic culture conditions confirmed that in about 50% of Tet2 −/− mice, live bacteria-in particular Lactobacillus-were present. Lactobacillus has previously been reported to be predominantly located in the small intestine under steady-state conditions 16 ( Fig. 1d-f , and Extended Data Fig. 1l ). No bacterial dissemination was observed in littermate controls (Fig. 1d-f ).
The existence of spontaneous bacterial translocation in Tet2
−/− mice was unexpected, given the absence of intestinal anomalies (Extended Data Fig. 2a ) and epithelial cell death (Extended Data Fig. 2b, c) in Tet2 −/− mice. However, increased intestinal permeability can occur in mice and humans with normal intestinal architecture 17 . Consistent with the observed microbial translocation, Tet2 −/− mice displayed a significant increase in intestinal permeability as assessed by in vivo FITC-dextran intestinal permeability assay (Fig. 2a) . Increased intestinal permeability positively correlated with PMP severity in Tet2 −/− mice (Fig. 2b, c and Extended Data Fig. 3a) , suggesting that disruption of intestinal barrier integrity may be sufficient to initiate PMP in symptom-free Tet2 −/− mice. Accordingly, administration of dextran sodium sulfate (DSS)-a compound known to alter intestinal barrier function 18 -caused excessive myeloproliferation and extramedullary haematopoiesis that persisted more than one month after cessation of treatment in symptom-free Tet2 f/f Vav cre mice, but not in littermate controls (Fig. 2d , e and Extended Data Fig. 3b-d 
Vav cre mice (Tet2 deleted in haematopoietic cells including progenitors) were used because somatic TET2 mutations occur in the haematopoietic compartment in humans [1] [2] [3] [4] [5] [6] [7] . These results suggest that maintaining intestinal barrier function is important for preventing PMP in the context of Tet2 deficiency in haematopoietic cells.
Whole transcriptome sequencing analysis of the intestine of Tet2 −/− and littermate control mice revealed major transcriptional alterations in the jejunum, but minor changes were also detected in the colon (Extended Data Fig. 4a ). This finding is consistent with the Centre is mean, one-way ANOVA, Sidak's post hoc test. In e, f, centre is median, Kruskal-Wallis, Dunn's post hoc test. Data are representative of at least two independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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observation that Lactobacillus spp. residing in the small intestine 16 were predominantly found in peripheral organs of Tet2 −/− mice. Consistent with Tet2-deficient mice displaying increased intestinal permeability (Fig. 2a) , the expression of genes known to maintain intestinal immune homeostasis and barrier function was altered in the jejunum (Extended Data Fig. 4b ). In particular, tight junction zonula occludens-1 (ZO-1), which is critical in regulating the paracellular leakage pathway 19 , was reduced in the jejunum but not in the colon of Tet2-deficient mice (Extended Data Fig. 4c-d Fig. 5a-c) . Consistent with these findings, and as previously shown 8, 21 , PMP developed only in Tet2 f/f Vav cre mice (Extended Data Fig. 5d-f ). These observations suggest that Tet2 deficiency in the haematopoietic compartment can promote small-intestinal barrier dysfunction that causes bacterial translocation.
To further assess whether the translocated bacteria were primarily of jejunal origin, we matched oligotypes 22 of identified bacterial strains in the spleen and MLN of Tet2 −/− mice with bacteria residing in the different intestinal compartments (Extended Data Fig. 1l and Supplementary Table 4 ). Consistent with the proposed hypothesis, Lactobacillus reuteri #5529 (number refers to oligotype), Lactobacillus johnsonii #5433 and Lactobacillus intestinalis #0092 were substantially enriched in the jejunum independent of the genotype, when compared to the colon (Fig. 2f) .
We first assessed whether TLR2 agonists-cell wall components of several Lactobacillus strains 23 -are relevant bacterial signals in Tet2 −/− mice (Extended Data Fig. 6a ), and then showed that the TLR2 agonist Pam3CSK4 was sufficient to induce extensive myeloproliferation in symptom-free Tet2 f/f Vav cre mice but not in littermate controls (Fig. 2g-h and Extended Data Fig. 6b-d) , without affecting intestinal barrier integrity (Extended Data Fig. 6e ). Of note, L. reuteri #5529 and L. johnsonii #5433 are also found in the small intestine of littermate control mice (Fig. 2f ) and 16S microbiome profiling failed to detect significant differences in microbial structures between genotypes (Extended Data Fig. 7a-d Data Fig. 7e ). These observations indicate that changes in microbial structures do not drive PMP and that systemic microbial signals, such as TLR2 agonists, may be sufficient to promote PMP independently of intestinal barrier dysfunction in Tet2-deficient mice. This is consistent with previous epidemiological studies that report an association between clonal expansion and myeloid malignancies with antecedent chronic inflammatory conditions of infectious origin 24 .
To demonstrate that microbial signals are required for the development of PMP, we raised Tet2 −/− mice under germ-free conditions. Forty-week-old Tet2 −/− germ-free mice failed to show signs of PMP in the peripheral blood and the spleen, in contrast to age-matched specific-pathogen-free (SPF)-raised Tet2 −/− mice (Fig. 3a, b and Extended Data Fig. 8a, b) . Furthermore, treatment with antibiotics ( Fig. 3c ) both −/− mice analysed for frequency (f, left) and number (f, right) of CD11b + Gr1 + myeloid cells and (g) 16S gene copies before, during and after ABX treatment (n = 7 mice). Mean ± s.e.m., repeated measures one-way ANOVA, Sidak's post hoc test. a, b, e, Centre is mean, one-way ANOVA, Sidak's post hoc test. Data are representative of at least two independent experiments; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. −/− mice. The longitudinal study that was performed in the presence of antibiotics and after antibiotic withdrawal (Fig. 3c ), using the peripheral-blood PMP marker (Fig. 3f, g and Extended Data Fig. 8d ), indicated that the potential for PMP remains and is directly linked to the presence of bacterial signals.
Interleukin 6 (IL-6) is a critical activator of myelopoiesis in response to systemic bacterial dissemination 15 and can be upregulated in chronic myeloproliferative disease in humans 25 . Accordingly, IL-6 was significantly increased in both the plasma and spleen of Tet2 −/− mice with PMP, as compared to littermate controls ( Fig. 4a and Extended Data Fig. 10a ). The increase in IL-6 was microbiota-dependent and induced upon DSS and TLR2-agonist treatment in symptom-free Tet2-deficient mice that subsequently developed PMP ( 
GMPs, the cellular expansion of IL-6Rα
+ GMPs occurred only in SPFhoused Tet2 −/− mice (Fig. 4f ). This suggests that the increase in IL-6Rα expression is intrinsic to the cell and independent of microbial signals, whereas the expansion of IL-6Rα + GMPs requires the microbiota and IL-6 (Extended Data Fig. 8b ). Importantly, megakaryocyte-erythroid progenitors did not display increased IL-6Rα expression and signalling (Fig. 4d , e) and consequently failed to expand in Tet2 −/− mice under SPF conditions (Fig. 4f ). These data suggest that the development of PMP requires an exogenous microbial signal and an upregulation of IL-6Rα on GMPs that is driven in a cell-autonomous manner by Tet2 deficiency. Of note, increased IL-6 production in the plasma and spleen ( Fig. 4a and Extended Data Fig. 10a ) of Tet2 −/− mice correlated with an increase in the number of myeloid cells capable of producing IL-6 (Extended Data Fig. 10j) , rather than an increase in IL-6 production by mature myeloid cells (Extended Data Fig. 10k, l) . No increase in IL-6Rα expression in mature splenic Tet2 −/− , without anti-IL-6) mice). c, e, Mean ± s.e.m., two-way ANOVA, Sidak's post hoc test. d, f, i, Centre is mean, one-way ANOVA, Sidak's post hoc test. Data are representative of at least two independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Fig. 10m) Fig. 10o ) independently of barrier function restoration (Extended Data Fig. 10p, q) . These findings provide experimental support to studies in humans that suggest a role for IL-6 in the pathogenesis of haematological malignancies 27 . Our study demonstrates a critical role for microbial-mediated inflammatory (IL-6) signals in the development of PMP in the context of Tet2 deficiency. More specifically, these data suggest an IL-6 dependent cycle that is engaged upon bacterial translocation and leads to PMP in Tet2 −/− mice through the expansion of GMPs that express high levels of IL-6Rα in the absence of Tet2 (Extended Data Fig. 10r for a schematic of this model). The mechanisms through which Tet2 deficiency in haematopoietic cells leads to a microbiota-dependent impairment of gut barrier function remain to be addressed.
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This work raises the question of whether microbial-dependent inflammatory mediators, such as IL-6, are critical contributors to myeloid malignancies in humans by promoting PMP in patients with somatic TET2 mutations. Furthermore, our findings-in combination with a report indicating that the restoration of Tet2 expression after PMP has developed prevents secondary evolution towards leukaemia in Tet2
-suggest that blocking inflammatory bacterial signals in patients with TET2 deficiency and PMP may reduce the risk of progression to haematopoietic malignancies. Whether bacterial infections and events promoting the disruption of intestinal barrier function can create a permissive environment that evokes the acquisition of cooperative oncogenic mutations that lead to the development of leukaemia 10 remains to be determined. Irrespectively, our study will motivate a new line of investigations and the design of novel therapeutic strategies that target IL-6 in patients with PMP linked to somatic TET2 mutations to revert myeloproliferation and prevent the development of myeloid malignancies.
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MEthodS
Mice. Tet2
−/− mice have previously been described 8 . /J) mice were crossed with the haematopoietic-specific Vav-cre line (B6.Cg-Tg(Vav1-icre)A2Kio/J), the villus and crypt small and large intestinal epithelial cell-specific Villin-cre line (B6.Cg-Tg(Vil1-cre)997Gum/J), and the myeloid cell lineage-specific LysM-cre line (Lyz2tm1(cre)Ifo)), respectively. For the experiments, >20-week-old Tet2 −/− mice and littermate controls were used, unless indicated otherwise. Both female and male mice were used for experiments; no notable sex-dependent differences were found for the reported experiments. Mice were housed at the University of Chicago animal facilities under specific pathogen-free (SPF) conditions, where cages were changed on a weekly basis; ventilated cages, bedding, food and water (non-acidified) were autoclaved before use, ambient temperature maintained at 23 °C, and 5% Clidox-S was used as a disinfectant. Experimental breeding cages were randomly housed on two different racks in the vivarium, and all cages were kept on automatic 12-h light/dark cycles. Germ-free Tet2 −/− mice were generated by two-stage embryo transfer, as previously described 29 , bred to germ-free C57BL/6 wild-type mice to generate littermate controls and maintained in flexible film isolators in McMaster's Axenic Gnotobiotic Unit. Animal husbandry for both SPF and germ-free facilities, and experimental procedures, were performed in accordance with Public Health Service policy and approved by the University of Chicago Institutional Animal Care and Use Committees and the McMaster University Animal Care Committee. Gnotobiotic animal husbandry. Food, bedding and water (non-acidified) were autoclaved before transfer into the sterile isolators. Cages within isolators were changed weekly, and all the cages in the vivarium were kept on 12-h light/dark cycles. Microbiology testing of faecal (experimental mice) or of caecum samples (sentinel mice; aerobic and anaerobic culture, 16S qPCR) was performed every other week to confirm germ-free status. In vivo anti-IL-6 antibody treatment. Peripheral blood of >20-week-old Tet2 −/− mice and littermate controls was analysed for myelopoiesis by flow cytometry.
Tet2
−/− mice selected with increased myelopoiesis (>16% CD11b + Gr1 + ) in peripheral blood, and littermate controls, were subjected to weekly intraperitoneal injections of 1 mg anti-mouse IL-6 (MP5-20F3, Bio X Cell, BE0046) or 1 mg rat IgG isotype control (HRPN, Bio X Cell, BE0088), respectively. Two Tet2 −/− mice that did not respond to the anti-mouse IL-6 treatment (based on blood screening) were excluded from the study. After three weeks, mice were euthanized and analysed for signs of PMP in the peripheral blood and spleen. ) in peripheral blood and <30 g body weight underwent DSS colitis treatment as described 30 . In brief, mice received 3% DSS (MW: 36,000-50,000; MP Biomedicals) (w/v) in drinking water for 7 days and were then switched to regular drinking water. Weight was recorded every other day throughout the study. Mice were euthanized 30 days post-DSS feeding and analysed for PMP. Antibiotic treatment. Mice were treated with an antibiotic cocktail as previously described 31 . All antibiotics used are listed as follows (concentration used, company, catalogue number). In detail, in the first week mice received a daily intragastric gavage with 100 μl of a mixture of kanamycin (4 mg ml , Sigma-Aldrich, V2002). For the following three weeks antibiotics were administered in the autoclaved (non-acidified) drinking water at 50-fold dilution except for vancomycin, which was maintained at 0.5 mg ml . Autoclaved (non-acidified) water was used to dissolve antibiotics. Antibiotic water was prepared fresh and replaced weekly. In vivo intestinal permeability measurement. An in vivo assay to determine intestinal epithelial barrier permeability was performed using a FITC-labelled dextran method as previously described 32 . In detail, mice were withdrawn from both food and water for 4 h, weighed and then received 60 mg per 100 g body weight of a freshly prepared FITC-dextran (MW 4,000, Sigma-Aldrich, 46944) solution diluted to 60 mg ml −1 in sterile PBS by oral gavage. Blood was collected by cheek bleeding (~300-500 μl) 3 h post-gavage and plasma was collected by centrifugation of blood samples at 2,000g for 10 min at 4 °C. Fifty microlitres of blood plasma was transferred (in duplicate) into a flat-bottom 96-well plate (Corning, 3370) and analysis of FITC-dextran concentration was performed with a fluorescence spectrophotometer setup (Synergy, BioTek) with emission and excitation wavelengths of 520 nm and 490 nm, respectively. Plasma samples were protected from light at all times. FITC-dextran concentration was determined from a standard curve generated by serial dilution of FITC-dextran. Tissue collection and cell purification. Spleen, MLNs and bones (tibia and femur, both sides) were collected under a laminar flow hood with autoclaved tools under sterile conditions and weight of spleen was recorded. Peripheral blood was collected by cheek bleeding (after sterilizing cheeks with 70% ethanol wipes) into EDTA-coated (Thermo Fisher Scientific, MT-46034CI) 1.5-ml tubes. To obtain a single cell suspension, spleen and MLNs were mashed through a 70-μm cell strainer and bone marrow was flushed out with syringes filled with PBS and also mashed through a 70-μm cell strainer. Erylysis of 10 μl peripheral blood, spleen and bone marrow was performed using the Mouse Erythrocyte Lysing Kit (R&D Systems, WL2000). For analysis of splenic and bone marrow haematopoietic precursors the mouse Lineage Cell Depletion Kit (Miltenyi Biotec, 130-090-858) was used. Antibodies and flow cytometry. Single cell suspensions were pelleted and resuspended in FACS buffer (PBS, 2% FCS) for immunostaining and subsequent flow cytometry analysis. Excluding the haematopoietic progenitor cell staining, all cell suspensions were incubated with Fc Block (BD, 553142) before staining with fluorophore-conjugated monoclonal antibodies. 
RNA processing and RT-PCR.
Small and large intestines were removed and transferred into cold PBS. A piece (~5 mm) of whole intestinal tissue (duodenum, jejunum, ileum and colon) was soaked in RNAlater (Qiagen, 76106) at 4 °C for 48 h and then stored at −80 °C until further analysis. For RNA extraction a Tissue-Tearor Homogenizer (Biospec) was used. RNA was prepared using the RNeasy Mini Kit (Qiagen, 74136). cDNA synthesis was performed using GoScript (Promega, A5004) according to the manufacturer's instructions. Expression analysis was performed in duplicate via RT-PCR on a Roche LightCycler 480 using SYBR Green (Clontech, 639265). Expression levels were quantified and normalized to Gapdh expression using the following primer pairs (all mouse):
Gapdh forward: 5′-AGGTCGGTGTGAACGGATTTG-3′; Gapdh reverse: 5′-TGTAGACCATGTAGTTGAGGTCA-3′; Dsp forward: 5′-TAC ACCTCAGGG C TGGAAAC-3′; Dsp reverse: 5′-GGGCCAGTCTTAGCTCCTCT-3′; Retnlb forward: 5′-ATGAAGCCTACACTGTGTTTCC-3′; Retnlb reverse: 5′-CTGCCAGAAGACGTGACACT-3′; Tjp1 forward: 5′-ACTCCCAC TTCCCCAAAAAC-3′; Tjp1 reverse: 5′-CCACAGCTGAAG GACTCACA -3′; Ang4 forward: 5′-GGTTGTGATTCCTCCAACTCTG-3′; Ang4 reverse: 5′-CTGAAGTTTTCTCCATAAGGGCT-3′; Ocln forward: 5′-ACTGG GTCAGGGAATATCCA-3′; Ocln reverse: 5′-TCAGCAGCAGCCATG TACTC-3′; Il6 forward: 5′-CCAAGAGGTGAGTGCTTCCC-3′; Il6 reverse: 5′-CTGTTGTTCAGACTCTCTCCCT-3′ RNA sequencing processing and data analysis. RNA sequencing libraries were prepared using the Illumina TruSeq protocol and sequenced with single-end 100-bp reads on an Illumina HiSeq2500. Adaptor sequences and low quality score bases were first trimmed using Trim Galore. The resulting reads were aligned to the mouse genome reference sequence (GRCm38/mm10) using the TopHat2 software package 33 with a TopHat transcript index from Ensembl. The number of read fragments overlapping with annotated exons of genes was tabulated using HTSeq 34 using the following parameters: -q -m intersection-nonempty -s no. Non-coding or low-expressed genes with an average read count lower than 10 were discarded, resulting in 15,045 genes in total. Using normalized gene counts for three Tet2 +/+ and three Tet2 −/− samples for each of the four tissue compartments, we identified differentially expressed genes using the R package limma 35 . Our linear model had the following design: Expression ~ Genotype:Tissue. Once we identified jejunum as the tissue with the largest differences in gene expression between Tet2
+/+ and
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Tet2
−/− samples, we increased our sample size for this tissue for a total of seven Tet2 +/+ and seven Tet2 −/− jejunum samples. We corrected for batch effects between the first and second set of samples using ComBAT 36 . We considered a gene as differentially expressed if statistically supported at a Q-value 37 false discovery rate <0.1 and a |log 2 (fold change)| > 0.5. Bacterial cultures and species identification. Organs were aseptically removed, weighed and transferred immediately to an anaerobic chamber (Coy Systems) for manual homogenization in 300 μl of pre-reduced (autoclaved, sterile filtered (0.22 μm), oxygen reduced with vacuum degasification) PBS + 0.1% l-cysteine (Sigma-Aldrich, 168149). Homogenates (100 μl per plate) were plated onto BD BBL Brucella agar with 5% sheep blood, Hemin and vitamin K1 agar plates (Fisher Scientific, L97848) and incubated anaerobically. For aerobic cultures tissue homogenates were plated onto Teknova brain heart infusion (BHI) agar plates (Fisher Scientific, 50-841-098) and incubated aerobically. Plates were sealed with parafilm and incubated upside down and after 48 h (aerobic) or 120 h (anaerobic) the colony-forming units (CFUs) were quantified. Results are displayed as CFUs per gram (g) tissue.
Representative bacterial colonies grown on agar plates were picked with sterile pipette tips and stored at −80 °C until analysis. At day of analysis picked bacterial colonies were thawed at room temperature, resuspended with 6 μl of sterile water and bacteria were lysed by heating up the samples to 95 °C for 10 min. Samples were subsequently cooled down to 4 °C and then the DNA (2 μl) was used as template DNA in PCR reactions amplifying the 16S rRNA gene using universal bacterial 16S rRNA primers (27F, 5′-AGAGTTTGATCMTGGCTCAG-3′ and 1525R, 5′-AAGGAGGTGATCCAGCC-3′) with reaction conditions: 95 °C for 5 min followed by 35 cycles of 95 °C for 30 s, 55 °C for 30 s, 72 °C for 2 min and then 72 °C for 20 min. The amplification product (10 μl) was incubated with 2 μl ExoSAP-IT (Thermo Fisher, 78200.200.UL) for 37 °C for 15 min, followed by 80 °C for 15 min. Amplicons were sequenced by capillary sequencing, and the resulting sequences were analysed using BLASTN and the 16S ribosomal RNA sequences database for species identification 38 . Bacterial lysates. Individual bacterial strains were grown up anaerobically in lactobacillus MRS broth (Fisher Scientific, DF0881-17-5) for 48 h, and sonicated for 3 × 20 s in cold PBS. The homogenate was centrifuged at 10,000g for 20 min to remove debris and filtered through a 0.2-μM filter. 16S copies of the homogenate were quantified by qPCR using the universal primers (340F, 5′-ACTCCTACGGGAGGCAGCAGT-3′) and (514R, 5′-ATTACCGCGGCTGCTGGC-3′) and purified genomic DNA from Blautia producta (Prevot) (ATCC, 27340D-5) as a standard 39 . HEK-TLR2 Quanti-Blue secreted embryonic alkaline phosphatase reporter assay. HEK-Blue TLR2 cells (provided by the Gajewski laboratory) were plated in HEK-Blue detection medium (InvivoGen, hb-det2) containing a substrate for alkaline phosphatase at 5 × 10 4 cells per well in 96-well plates and incubated with different concentrations of Pam3CSK4 (InvivoGen, tlrl-pms), LPS (InvivoGen, tlrlpeklps) or bacterial lysates normalized to 16S rRNA copies. Alkaline phosphatase activity was measured after 5 h by reading optical density at 620 nm. DNA extraction from tissue or faeces for 16S qPCR. Total DNA was extracted from organs (collected under sterile conditions, ~30 mg spleen, ~30 mg MLN and 50 μl peripheral blood) and faeces using the DNeasy Blood & Tissue Kit (Qiagen, 69504) and the Fast DNA Stool Mini Kit (Qiagen, 51604), respectively. Quantitative PCR (qPCR) of 16S rRNA-encoding genes was performed as previously described 30 . In brief, qPCR was performed on a Roche LightCycler 480 (Roche Scientific) using the primers (340F, 5′-ACTCCTACGGGAGGCAGCAGT-3′) and (514R, 5′-ATTACCGCGGCTGCTGGC-3′). Reactions were run at 95 °C for 3 min, followed by 40 cycles of 95 °C for 15 min and 63 °C for 60 s. Specific amplification of targets was quantified using dilution curves of a purified pCR4-TOPO vector (Invitrogen) containing a cloned 16S rRNA-encoding gene from Blautia producta (Prevot) (ATCC, 27340D-5) as a standard 39 for both blood and faeces. Standards ranging in concentration from 10 8 -10 0 plasmid copies per μl were run in parallel with our samples for both blood and faeces during each qPCR run. Using those results, a standard curve was generated to quantify the number of copy numbers within the samples. To determine the bacterial load in the faeces samples, the results were normalized to faecal weight. Bacterial 16S rRNA gene qPCRs from MLN and spleen were normalized to the host murine Ifnb1 gene (forward: 5′-CCATCCAAGAGATGCTCCAG-3′; reverse 5′-GTGGAGAGCAGTTGAGGACA-3′). C57BL/6 wild-type germ-free mice served as negative control (Fig. 1b) . 16S rRNA amplicon library preparation, sequencing and data analysis. Faeces, jejunal and colon contents, and mucosal scrapings from the jejunum were collected and snap-frozen in liquid nitrogen. Bacterial DNA was extracted using the Fast DNA Stool Mini Kit (Qiagen, 51604). 16S rRNA amplicon library preparation and sequencing was performed as previously described 30 . Raw sequencing data were de-multiplexed, and partially overlapping paired-end reads were merged using illumina-utils 40 . Mismatches at the overlapping regions of pairs were resolved using the base with the higher Q-score, and the merged sequences were kept for downstream analyses only (1) if they contained less than three mismatches at the overlapping region, and (2) if 66% of the bases in the first half of each read had an average Q-score of 30. The quality-filtered reads were partitioned into ecologically relevant units using minimum entropy decomposition (MED) 41 with default parameters. Using Shannon entropy, MED resolves a given amplicon dataset iteratively into oligotypes, which are able to describe differences between microbial groups at a single-nucleotide resolution 22 . The taxonomy of oligotypes was inferred through GAST 42 . The metaMDS function in the vegan 43 library was used to generate ordinations of samples based on their oligotype profiles using non-metric multidimensional scaling with Bray-Curtis distances, and the envfit function in vegan with 999 permutations was used to test whether the genotype or the source of samples were significantly associated with differences between microbiomes. The pheatmap library for R was used to generate heat-map displays of the sample oligotype profiles, and the hierarchical clustering of samples in heat maps employed Bray-Curtis distances, and the average linkage algorithm. Analysis of cytokine production in blood plasma and intestinal explants. Blood was collected by cheek bleeding (after sterilizing cheeks with 70% ethanol wipes) in EDTA (Thermo Fisher Scientific, MT-46034CI)-coated tubes, centrifuged at 2,000g for 10 min at 4 °C and plasma was stored at −80 °C until cytokine analysis. One-centimetre pieces from the jejunum and colon were collected, opened longitudinally, washed in PBS and explants were cultured in 500 μl RPMI 1640 medium (Fisher Scientific, MT-10-040-CV) containing 10% FBS, 200 U ml −1 penicillin, and 200 μg ml −1 streptomycin (MP Biomedicals, 091670249) for 48 h. The IL-6 cytokine amount in blood plasma and in supernatants of intestinal explants was determined with BioPlex multianalyte technology (Biorad) according to manufacturer's instructions. In vitro haematopoietic methylcellulose colony-forming assay. Similar to a related study 9 , lineage depleted (mouse Lineage Cell Depletion Kit (Miltenyi Biotec, 130-090-858) haematopoietic progenitors of the bone marrow and the spleen were seeded in duplicate in cytokine-supplemented methylcellulose (MethoCult, M3434, STEMCELL Technologies) at a density of 5,000 cells per plate (bone marrow) or 25,000 cells per plate (spleen). Colonies were counted every 7 days and 10,000 cells per plate were seeded for replatings. The average number of colonies per 10,000 plated cells is shown for 5 sequential platings. For anti-mouse IL-6 antibody (MP5-20F3, Bio X Cell, BE0046) and isotype (HRPN, Bio X Cell, BE0088) treatment, anti-IL-6 antibody or isotype was freshly added to the cytokine-supplemented methylcellulose medium before every replating at a concentration of 100 μg ml −1 . Haematoxylin and eosin staining. Jejunum was flushed with cold PBS (GE Healthcare Life Science, SH30028.02) followed by immediate flushing with 10% formalin (Fisher Scientific, L14416). A section of ~3 cm from jejunum was cut with a razor blade, cut open longitudinally and pinned out with needles in wax boxes. Tissue was fixed for 24 h at room temperature and pre-embedded in 2% agar (Sigma, A7921). Haematoxylin and eosin staining was performed on 5-μm paraffinembedded intestinal sections. The haematoxylin and eosin stained slides were digitized (objective: ×20; camera: CIS 3CCD 2 Mega Pixel) with the Pannoramic MIDI Scan System (3DHISTECH). The Panoramic viewer software (3DHISTECH) was used for imaging. Immunofluorescence staining. For ZO-1 staining, jejunum and proximal colon was dissected and cross-sections were frozen in optimum cutting temperature compound (Tissue-Tek). Frozen sections of 5-μm thicknesses were cut and fixed in 1% paraformaldehyde in 1× PBS for 30 min at room temperature. After washing in PBS, three 5-min incubations in PBS with 50 mM NH 4 Cl were performed, followed by permeabilization in PBS with 0.5% NP-40 for 20 min, and three additional 5-min washes in PBS. Tissue sections were then incubated with mouse IgG ZO-1 monoclonal antibody (ZO1-1A12, Thermo Fisher Scientific, 33-9100) in PBS with 10% normal donkey serum overnight at 4 °C, washed five times with PBS with 1% normal donkey serum (5 min each) and incubated with Alexa Fluor 594-conjugated donkey anti-mouse (IgG, Jackson ImmunoResearch, 715-586-151) and Hoechst 33342 (ThermoFisher Scientific, H3570) for 1 h at room temperature. After incubation, tissue was washed five times with PBS with 1% normal donkey serum (5 min each) and mounted in Pro-Long Gold slides followed by imaging using an Olympus IX81 inverted microscope with a Photometrics CoolSNAP HQ2 camera. For cleaved caspase 3 and TUNEL staining, jejunum was dissected and cross-sections were fixed in 10% formalin, and then processed for paraffin sectioning. Five-micrometre sections were dewaxed by immersion in xylene and hydrated by serial immersion in ethanol and PBS. Antigen retrieval was performed by incubating sections in a pressure cooker (Cuisinart) for 15 min in Target Retrieval Solution (DAKO, S1699). Sections were washed with PBS (twice for 10 min), and blocking buffer (TBS containing 10% BSA (EMD Millipore Sigma, 82-045-1) and OmniPur Triton X-100 (0.3%, EMD Millipore Sigma, 9400) was added for 1 h. Sections were incubated with anti-pan-keratin (dilution 1:200, ABCAM, ab6401) and anti-cleaved caspase 3 (dilution 1:500, Cell Signaling Technology, 9661S) antibody in blocking buffer overnight at 4 °C and then incubated with goat Letter reSeArCH anti-mouse IgG1 Alexa Fluor 488 (Thermo Fisher Scientific, A21121) or goat anti-rabbit Alexa Fluor 594 (Thermo Fisher Scientific, A11037) labelled secondary antibodies (dilution 1:400, Thermo Fisher Scientific) for 30 min. Sections were mounted with Fluoromount-G (Beckman Coulter, 731604). DNA fragmentation in gut sections was assayed by TUNEL assay in formalin-fixed sections according to the manufacturer's instructions (Roche Applied Science, 12156792910). Sections were stained with DAPI (10 μg ml −1 , Invitrogen, D1306) and mounted with Fluoromount-G (Beckman Coulter, 731604). As a positive control, jejunum sections of VDTR mice (mice expressing diphtheria toxin receptor under the villin promoter (epithelial specific)) treated with 10 ng of diphtheria toxin per g of body weight, for 12 h, were used 44 . Statistical analysis. The majority of experiments were repeated at least three times to obtain data for indicated statistical analyses. Mice were allocated to experimental groups on the basis of their genotype and randomized within the given sex-and age-matched group. Because our mice were inbred and matched for age and sex, we always assumed similar variance between the different experimental groups. We did not perform an a priori sample size estimation but always used as many mice per group as possible in an attempt to minimize type Ι and type ΙΙ errors. Investigators were not blinded during experiments and outcome assessment, except for microscopic analysis of fluorescent immunostaining, which was performed blinded. For bacterial culture experiments (aerobic and anaerobic) (Fig. 1d) a representative image out of five biological replicate experiments is shown. For microscopy analyses (Extended Data Figs. 2a-c, 4d, 10g ) representative images out of at least three biological replicate experiments are shown. All experimental and control animals were littermates and none were excluded from the analysis at the time of collection. The number of mice per group is described in the corresponding figure legends as n and all quantitative data are presented as mean ± error of the mean (s.e.m.), unless otherwise indicated. Data were first analysed for normal distribution using D' Agostino and Pearson omnibus normality tests. Normally distributed data were analysed using a paired or unpaired two-tailed Student's t-test for single comparisons, and one-way or two-way ANOVA for multiple comparisons. ANOVA analysis was followed by a Sidak's post hoc test. Data that were not normally distributed were analysed using unpaired two-tailed Mann-Whitney U-test for single comparisons, and Kruskal-Wallis, Dunn's post hoc test for multiple comparisons. Correlations were calculated using the Pearson and Spearman correlation. Figures and statistical analysis were generated using GraphPad Prism 6 (GraphPad Software). The statistical test used and P values are indicated in each figure legend. P values of <0.05 were considered to be statistically significant. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper.
Data availability. Datasets that support the findings of this study have been deposited online in the Gene Expression Omnibus (GEO) under accession number GSE99333. Source Data for all mouse experiments have been provided. All other data are available from the corresponding author upon reasonable request.
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Extended Data Fig. 1 g, Spleen weight (top; n = 11 (blue), 9 (red, PMP) or 5 mice (red, symptom free)) and numbers of CD11b + Gr1 + myeloid cells in the spleen (bottom; n = 10 (blue), 12 (red, PMP) or 7 mice (red, symptom free)). h, Numbers per ml of peripheral blood of live CD45 + gated white blood cells (WBC) (top left), lymphocytes (top right), CD11b
+ monocytes (bottom left) and CD11b + Gr1 + myeloid cells (bottom right) (n = 15 (blue), 15 (red, PMP) or 32 mice (red, symptom free)). i, In vitro HSC self-renewal colony-forming assay of haematopoietic progenitors of the bone marrow (n = 3 mice). Mean ± s.e.m. j, k, Correlation between 16S gene copies in the peripheral blood and spleen weight (n = 16 mice) (j) or numbers of CD11b . In a-f, centre is mean, one-way ANOVA, Sidak's post hoc test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Data are representative of three independent experiments. 1 nature research | life sciences reporting summary
November 2017
Corresponding author(s): Bana Jabri Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Please do not complete any field with "not applicable" or n/a. Refer to the help text for what text to use if an item is not relevant to your study. For final submission: please carefully check your responses for accuracy; you will not be able to make changes later.
Experimental design 1. Sample size
Describe how sample size was determined.
The majority of experiments were repeated at least three times to obtain data for indicated statistical analyses. Mice were allocated to experimental groups on the basis of their genotype and randomized within the given sex-and age-matched group. Given that our mice were inbred and matched for age and sex, we always assumed similar variance between the different experimental groups. We did not perform an a priori sample size estimation but always used as many mice per group as possible in an attempt to minimize type Ι and type ΙΙ errors.
Data exclusions
Describe any data exclusions.
All experimental and control animals were littermates and none were excluded from the analysis at the time of harvest.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
The majority of experiments were repeated at least three times to ensure reproducibility. Statistical analysis were done to illustrate significance. All attempts to replicate experiments were sucessful
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Mice were allocated to experimental groups on the basis of their genotype and randomized within the given sex-and age-matched group.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Investigators were not blinded during experiments and outcome assessment, except for micr oscopic analysis of fluorescent immunostaining, which has been performed blinded Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
No unique materials were used
